Antiarrhythmic agent (Class III) — atrial fibrillation
Generic name: dronedarone
US Retail Price
$400–$500/month
With copay card: Reduced cost for eligible patients
Manufacturer
Sanofi
Used For
Paroxysmal or persistent atrial fibrillation (AFib) or atrial flutter to reduce cardiovascular hospitalization
Multaq (dronedarone) is contraindicated in patients with permanent atrial fibrillation, severe heart failure (NYHA Class IV or recent decompensation), and second/third-degree AV block. Generic dronedarone became available in the US in 2022 and is significantly cheaper than brand-name Multaq.
Generic dronedarone became available in the US in 2022. With a GoodRx coupon, prices can be significantly less than brand-name Multaq. Check GoodRx for the lowest price near you.
Check Generic Price on GoodRxSanofi offers a savings card program for brand-name Multaq for commercially insured patients. Check the Multaq website for current eligibility and savings amounts.
Apply for Multaq Savings CardVerified international pharmacies sell brand-name Multaq for significantly less than US retail. Use PharmacyChecker to compare verified sources.
Compare International PricesSanofi offers patient assistance for those who meet income requirements. Search NeedyMeds for the Multaq PAP application.
Search Multaq PAP on NeedyMedsLooking for another medication?
The Med Map covers all 8 categories of savings options for hundreds of drugs.
Back to The Med Map